Cantargia has appointed Dr Hilde Steineger as its new Chief Executive Officer, effective September 1. Dr Steineger, a seasoned biotechnology executive, joins from NorthSea Therapeutics.
Company Information
Company
Cantargia AB
Location
27 Scheelevaegen
Lund, Skåne County, Sweden
About
Cantargia AB is a publicly traded biopharmaceutical company focused on the development of treatments for autoimmune and inflammatory diseases. The company works on innovative therapies leveraging its expertise in clinical development and regulatory strategies. It is dedicated to improving the quality of life for patients by addressing unmet medical needs.
Fundz sees it the moment Cantargia AB changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
LundBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaresearch